Integra LifeSciences (IART) Tops Q2 EPS by 1c; Updates FY11 Outlook, Revs Above Street
Tweet Send to a FriendGet Alerts IART Hot Sheet
Trade IART Now!
Integra LifeSciences Holdings (NASDAQ: IART) reported Q2 EPS of $0.70, $0.01 better than the analyst estimate of $0.69. Revenue for the quarter came in at $193.3 million versus the consensus estimate of $188.78 million.
Integra LifeSciences Holdings sees FY2011 EPS of $2.92-$3.02, versus the consensus of $2.98. Integra LifeSciences Holdings sees FY2011 revenue of $785-$800 million, versus the consensus of $783.55 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Integra LifeSciences Holdings sees FY2011 EPS of $2.92-$3.02, versus the consensus of $2.98. Integra LifeSciences Holdings sees FY2011 revenue of $785-$800 million, versus the consensus of $783.55 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Qihoo 360 Technology (QIHU) Reports In-Line Q1 EPS; Guides Q2 Sales
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
